Table 4.
AP (U/l) | Bilirubin (mg/dl) | |
Dilatation group* | ||
Before treatment | 1806 | 11.1 |
After treatment | 1117 | 2.3 |
Group with EPT and sludge extraction† | ||
Before treatment | 637 | 15 |
After treatment | 102 | 6.5 |
UDCA only group‡ | ||
Before treatment | 2017 (1675)§ | 17.7 (14.2)§ |
After treatment | 1236 (1114 )§ | 13.7 (7.3)§ |
*Patients with endoscopic dilatations and ursodeoxycholic acid (UDCA) treatment (Nos 3, 6, and 7).
†Patients with endoscopic sphincterotomy of the papilla (EPT), sludge extraction, and UDCA treatment (Nos 1 and 9).
‡Patients with UDCA treatment only (Nos 2, 4, 5, and 8).
§Data calculated without patient No 4 who did not respond to therapy.
AP, alkaline phosphatase.